Depression Research Today is a free monthly online journal that collates and summarizes the latest research about Depression, including details on clinical depression, medication, symptoms, treatment, counselling, therapy.

Volume 2 (2005), Issue 5 (May)

1. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study.
   Am J Psychiatry, 162(5): 977-82. [Abstract] [Full-text]
2. The impact of comorbid posttraumatic stress disorder on short-term clinical outcome in hospitalized patients with depression.
   Am J Psychiatry, 162(5): 970-6. [Abstract] [Full-text]
3. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression.
   Br J Psychiatry, 186: 410-6. [Abstract] [Full-text]
4. Care staff training in detection of depression in residential homes for the elderly: randomised trial.
   Br J Psychiatry, 186: 404-9. [Abstract] [Full-text]
5. Birth dimensions and risk of depression in adulthood: cohort study of Danish men born in 1953.
   Br J Psychiatry, 186: 400-3. [Abstract] [Full-text]
6. Postpartum "psychosis" in mild argininosuccinate synthetase deficiency.
   Obstet Gynecol, 105(5): 1244-6. [Abstract] [Full-text]
7. Depression screening instruments made good severity measures in a cross-sectional analysis.
   J Clin Epidemiol, 58(4): 370-7. [Abstract] [Full-text]
8. Provider type and depression treatment adequacy.
   Health Policy, 72(3): 321-32. [Abstract] [Full-text]
9. Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.
   Brain Res, 1043(1): 57-64. [Abstract] [Full-text]
10. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache.
    Eur J Pain, 9(3): 285-91. [Abstract] [Full-text]
11. Hypofrontality and microvascular dysregulation in remitted late-onset depression assessed by functional near-infrared spectroscopy.
    Neuroimage, 26(1): 234-42. [Abstract] [Full-text]
12. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
    Phytother Res, 19(2): 148-51. [Abstract] [Full-text]
13. Depressive symptom quality and neuropsychological performance in dementia.
    Int J Geriatr Psychiatry, 20(5): 479-84. [Abstract] [Full-text]
14. The CIDI as an instrument for diagnosing depression in older Turkish and Moroccan labour migrants: an exploratory study into equivalence.
    Int J Geriatr Psychiatry, 20(5): 436-45. [Abstract] [Full-text]
15. The Center for Epidemiologic Studies Depression Scale in older Chinese: thresholds for long and short forms.
    Int J Geriatr Psychiatry, 20(5): 465-70. [Abstract] [Full-text]
16. Does education moderate neuropsychological impairment in late-life depression?
    Int J Geriatr Psychiatry, 20(5): 413-7. [Abstract] [Full-text]
17. Major depression as a risk factor for early institutionalization of dementia patients living in the community.
    Int J Geriatr Psychiatry, 20(5): 471-8. [Abstract] [Full-text]
18. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice.
    Psychopharmacology (Berl), 179(3): 637-43. [Abstract] [Full-text]
19. Depression and the use of complementary medicine among breast cancer patients.
    Support Care Cancer, 13(5): 339-42. [Abstract] [Full-text]
20. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
    Arch Gen Psychiatry, 62(5): 537-44. [Abstract] [Full-text]
21. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication.
    Arch Gen Psychiatry, 62(5): 529-35. [Abstract] [Full-text]
22. Predicting depression following mild traumatic brain injury.
    Arch Gen Psychiatry, 62(5): 523-8. [Abstract] [Full-text]
23. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Arch Gen Psychiatry, 62(5): 513-20. [Abstract] [Full-text]
24. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus.
    Pediatrics, 115(5): 1315-9. [Abstract] [Full-text]
25. Psychological adaptation of liver transplant recipients.
    Transplant Proc, 37(3): 1502-4. [Abstract] [Full-text]
26. Reduced sustained brain activity during processing of positive emotional stimuli in major depression.
    Biol Psychiatry, 57(10): 1089-96. [Abstract] [Full-text]
27. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study.
    Biol Psychiatry, 57(10): 1079-88. [Abstract] [Full-text]
28. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 565-70. [Abstract] [Full-text]
29. Higher cortisol levels in spring and fall in patients with major depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 529-34. [Abstract] [Full-text]
30. Do others really know us better? Predicting migraine activity from self- and other-ratings of negative emotion.
    J Psychosom Res, 58(3): 253-8. [Abstract] [Full-text]
31. Controlled and automatic uses of memory in depressed patients: effect of retention interval lengths.
    Behav Res Ther, 43(5): 681-90. [Abstract] [Full-text]
32. Management of depression after stroke: a systematic review of pharmacological therapies.
    Stroke, 36(5): 1098-103. [Abstract] [Full-text]
33. Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions.
    J Thromb Haemost, 3(5): 897-908. [Abstract] [Full-text]
34. Self-stigma and its correlates among outpatients with depressive disorders.
    Psychiatr Serv, 56(5): 599-601. [Abstract] [Full-text]
35. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.
    J Clin Endocrinol Metab, 90(5): 2522-30. [Abstract] [Full-text]
36. Depression in women.
    Metabolism, 54(5): 49-52. [Abstract] [Full-text]
37. Depression and cardiovascular disease: a reciprocal relationship.
    Metabolism, 54(5): 45-8. [Abstract] [Full-text]
38. Subsyndromal depression in the elderly: underdiagnosed and undertreated.
    Metabolism, 54(5): 39-44. [Abstract] [Full-text]
39. Depression, cytokines, and glial function.
    Metabolism, 54(5): 33-8. [Abstract] [Full-text]
40. Depression and neurosurgery: past, present, and future.
    Metabolism, 54(5): 28-32. [Abstract] [Full-text]
41. Neurobiological basis of depression: an update.
    Metabolism, 54(5): 24-7. [Abstract] [Full-text]
42. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain.
    Metabolism, 54(5): 20-3. [Abstract] [Full-text]
43. Genes, stress, and depression.
    Metabolism, 54(5): 16-9. [Abstract] [Full-text]
44. Genetics and genomics of depression.
    Metabolism, 54(5): 10-5. [Abstract] [Full-text]
45. Overview of the field.
    Metabolism, 54(5): 5-9. [Abstract] [Full-text]
46. Behind the facial twitch: depressive symptoms in hemifacial spasm.
    Parkinsonism Relat Disord, 11(4): 241-5. [Abstract] [Full-text]
47. Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales.
    Acta Psychiatr Scand, 111(6): 453-9. [Abstract] [Full-text]
48. Caring for a person with dementia: exploring relationships between perceived burden, depression, coping and well-being.
    Nurs Health Sci, 7(2): 81-91. [Abstract] [Full-text]
49. Effect of race and sex on primary care physicians' diagnosis and treatment of late-life depression.
    J Am Geriatr Soc, 53(5): 777-84. [Abstract] [Full-text]
50. Major depression and the use of electroconvulsive therapy (ECT) in lung transplant recipients.
    Psychosomatics, 46(3): 244-9. [Abstract] [Full-text]
51. Relationship of tumor burden and patients' minimization of distress in facing surgery for gastric cancer.
    Psychosomatics, 46(3): 233-43. [Abstract] [Full-text]
52. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study.
    Psychosomatics, 46(3): 224-32. [Abstract] [Full-text]
53. History of depression and women's current health and functioning during midlife.
    Gen Hosp Psychiatry, 27(3): 200-8. [Abstract] [Full-text]
54. Approximal plaque and gingival sulcus bleeding in routine dental care patients: relations to life stress, somatization and depression.
    J Clin Periodontol, 32(6): 575-82. [Abstract] [Full-text]
55. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
    J Hepatol, 42(6): 880-7. [Abstract] [Full-text]
56. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    J Hepatol, 42(6): 793-8. [Abstract] [Full-text]
57. Developing a culturally appropriate depression prevention program: the family coping skills program.
    Cultur Divers Ethnic Minor Psychol, 11(2): 99-112. [Abstract] [Full-text]
58. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort.
    Arthritis Rheum, 52(5): 1577-84. [Abstract] [Full-text]
59. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients.
    J Psychopharmacol, 19(3): 267-75. [Abstract] [Full-text]
60. Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression.
    J Lipid Res, 46(6): 1093-6. [Abstract] [Full-text]
61. Body mass, depressive symptoms and menopausal status: an examination of the "Jolly Fat" hypothesis.
    Womens Health Issues, 15(3): 145-51. [Abstract] [Full-text]
62. Long-term consequences of childhood sexual abuse by gender of victim.
    Am J Prev Med, 28(5): 430-8. [Abstract] [Full-text]
63. Depression in persons with multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 437-48, ix. [Abstract] [Full-text]
64. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
    Drug Alcohol Depend, 78(3): 309-15. [Abstract] [Full-text]
65. Proposed multigenic Composite Inheritance in major depression.
    Med Hypotheses, 65(1): 158-72. [Abstract] [Full-text]
66. 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin.
    Med Hypotheses, 65(1): 138-44. [Abstract] [Full-text]
67. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
    Med Hypotheses, 65(1): 39-43. [Abstract] [Full-text]
68. Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members.
    Soc Sci Med, 61(2): 305-11. [Abstract] [Full-text]
69. Predictors of screening results for depressive symptoms among homeless adults in Los Angeles with latent tuberculosis.
    Res Nurs Health, 28(3): 220-9. [Abstract] [Full-text]
70. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study.
    Arch Dermatol, 141(5): 557-60. [Abstract] [Full-text]
71. The relation of self-report of mood and anxiety to CVLT-C, CVLT, and CVLT-2 in a psychiatric sample.
    Arch Clin Neuropsychol, 20(4): 547-53. [Abstract] [Full-text]
72. Anxious-depression in boys: an evaluation of executive functioning.
    Arch Clin Neuropsychol, 20(4): 539-46. [Abstract] [Full-text]
73. Interpersonal psychotherapy: an effective psychotherapeutic intervention for mental health nursing practice.
    Int J Ment Health Nurs, 14(2): 126-33. [Abstract] [Full-text]
74. Medical complaints among Iraqi American refugees with mental disorders.
    J Immigr Health, 7(3): 145-52. [Abstract] [Full-text]
75. The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: implications for service directions.
    AIDS Educ Prev, 17(2): 119-30. [Abstract] [Full-text]
76. The impact of parental borderline personality disorder on vulnerability to depression in children of affectively ill parents.
    J Personal Disord, 19(1): 68-83. [Abstract] [Full-text]
77. The process of change in Interpersonal Psychotherapy (IPT) for depression: a case study for the new IPT therapist.
    Psychiatry, 68(1): 43-54. [Abstract] [Full-text]
78. A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.
    Curr Med Res Opin, 21(4): 631-42. [Abstract] [Full-text]
79. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus.
    Proc Natl Acad Sci U S A, 102(20): 7362-7. [Abstract] [Full-text]
80. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
    Brain, 128: 1314-22. [Abstract] [Full-text]
81. The association between negative self-descriptions and depressive symptomology: does culture make a difference?
    Arch Psychiatr Nurs, 19(2): 93-100. [Abstract] [Full-text]
82. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression.
    Pharmacopsychiatry, 38(3): 139-43. [Abstract] [Full-text]
83. Paroxetine serum concentrations in depressed patients and response to treatment.
    Pharmacopsychiatry, 38(3): 118-21. [Abstract] [Full-text]
84. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
    Pharmacopsychiatry, 38(3): 113-7. [Abstract] [Full-text]
85. Factors associated with being a false positive on the General Health Questionnaire.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 402-7. [Abstract] [Full-text]
86. Are self-referrers just the worried well?--A cross-sectional study of self-referrers to community psycho-educational Stress and Self-Confidence workshops.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 396-401. [Abstract] [Full-text]
87. Early intervention for perinatal depression.
    Am J Obstet Gynecol, 192(5): 1446-8. [Abstract] [Full-text]
88. Remote psychotherapy for terminally ill cancer patients.
    J Telemed Telecare, 11(3): 157-9. [Abstract] [Full-text]
89. Adolescent motherhood and postpartum depression.
    J Clin Child Adolesc Psychol, 34(2): 292-300. [Abstract] [Full-text]
90. Childhood traumatic grief: an exploration of the construct in children bereaved on September 11.
    J Clin Child Adolesc Psychol, 34(2): 248-59. [Abstract] [Full-text]
91. The relations among abuse, depression, and adolescents' autobiographical memory.
    J Clin Child Adolesc Psychol, 34(2): 235-47. [Abstract] [Full-text]
92. Avoidance and processing as predictors of symptom change and positive growth in an integrative therapy for depression.
    Int J Behav Med, 12(2): 111-22. [Abstract] [Full-text]
93. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression.
    Int J Behav Med, 12(2): 86-97. [Abstract] [Full-text]
94. Using patient characteristics and attitudinal data to identify depression treatment preference groups: a latent-class model.
    Depress Anxiety, 21(2): 47-54. [Abstract] [Full-text]
95. A three-factor model of the MADRS in major depressive disorder.
    Depress Anxiety, 21(2): 95-7. [Abstract] [Full-text]
96. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression.
    Depress Anxiety, 21(2): 78-89. [Abstract] [Full-text]
97. Social anxiety disorder and depression in Saudi Arabia.
    Depress Anxiety, 21(2): 90-4. [Abstract] [Full-text]
98. Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample.
    Depress Anxiety, 21(2): 55-60. [Abstract] [Full-text]
99. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor.
    Mol Psychiatry, 10(5): 470-8. [Abstract] [Full-text]
100. Desire for hastened death, cancer pain and depression: report of a longitudinal observational study.
     J Pain Symptom Manage, 29(5): 446-57. [Abstract] [Full-text]
101. Immobility in the swim test and observations of maternal behavior in lactating Flinders sensitive line rats.
     Behav Brain Res, 161(1): 155-63. [Abstract] [Full-text]
102. Differentiating anxiety and depression symptoms in patients with partial epilepsy.
     Epilepsy Behav, 6(4): 563-9. [Abstract] [Full-text]
103. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis.
     Lancet Neurol, 4(6): 371-80. [Abstract] [Full-text]
104. Physical and mental health symptoms among NYC transit workers seven and one-half months after the WTC attacks.
     Am J Ind Med, 47(6): 475-83. [Abstract] [Full-text]
105. Contribution to the epidemiology of postnatal depression in Germany--implications for the utilization of treatment.
     Arch Women Ment Health, 8(1): 29-35. [Abstract] [Full-text]
106. Prevalence of postpartum depression in a Moroccan sample.
     Arch Women Ment Health, 8(1): 37-43. [Abstract] [Full-text]
107. A screening study of antidepressant treatment rates and mood symptoms in pregnancy.
     Arch Women Ment Health, 8(1): 25-7. [Abstract] [Full-text]
108. A new Mother-to-Infant Bonding Scale: links with early maternal mood.
     Arch Women Ment Health, 8(1): 45-51. [Abstract] [Full-text]
109. Mixed anxiety and depression in older adults: clinical characteristics and management.
     J Geriatr Psychiatry Neurol, 18(2): 83-8. [Abstract] [Full-text]
110. The role of everyday emotion regulation on pain in hospitalized elderly: insights from a prospective within-day assessment.
     Pain, 115(3): 355-63. [Abstract] [Full-text]
111. Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study.
     Pain, 115(3): 316-21. [Abstract] [Full-text]
112. Recovering the ability to function socially in elderly depressed patients: a prospective, controlled trial.
     Arch Gerontol Geriatr, 41(1): 41-9. [Abstract] [Full-text]
113. Stress and depression among medical students: a cross-sectional study.
     Med Educ, 39(6): 594-604. [Abstract] [Full-text]
114. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III.
     Am J Public Health, 95(6): 998-1000. [Abstract] [Full-text]
115. An investigation of the prevalence of depressive symptoms in soldiers during military training.
     Prev Med, 41(2): 642-5. [Abstract] [Full-text]
116. Self-recognition of and provider response to maternal depressive symptoms in low-income Hispanic women.
     J Womens Health (Larchmt), 14(4): 331-8. [Abstract] [Full-text]
117. Report from the CDC: mental health of women in postwar Afghanistan.
     J Womens Health (Larchmt), 14(4): 285-93. [Abstract] [Full-text]
118. Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: a cross-sectional survey.
     AIDS Patient Care STDS, 19(5): 317-25. [Abstract] [Full-text]
119. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
     Neuroscience, 133(2): 453-61. [Abstract] [Full-text]
120. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.
     Nat Neurosci, 8(6): 828-34. [Abstract] [Full-text]
121. Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong).
     Osteoporos Int, 16(6): 610-5. [Abstract] [Full-text]
122. The impact of comorbid anxiety and depression on alcohol treatment outcomes.
     Addiction, 100(6): 787-96. [Abstract] [Full-text]
123. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man.
     Psychoneuroendocrinology, 30(8): 807-14. [Abstract] [Full-text]
124. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.
     Mol Psychiatry, 10(6): 598-605. [Abstract] [Full-text]
125. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
     Mol Psychiatry, 10(6): 538-44. [Abstract] [Full-text]
126. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
     Clin Ther, 27(4): 486-96. [Abstract] [Full-text]
127. The multiple outcomes bias in antidepressants research.
     Med Hypotheses, 65(2): 395-9. [Abstract] [Full-text]
128. Anhedonia and motivational deficits in rats: impact of chronic social stress.
     Behav Brain Res, 162(1): 127-34. [Abstract] [Full-text]
129. Patient experiences of anxiety, depression and acute pain after surgery: a longitudinal perspective.
     Int J Nurs Stud, 42(5): 521-30. [Abstract] [Full-text]
130. Depression and health-related quality of life in elderly patients suffering from heart failure and their spouses: a comparative study.
     Eur J Heart Fail, 7(4): 583-9. [Abstract] [Full-text]
131. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.
     Med Hypotheses, 65(2): 287-95. [Abstract] [Full-text]
132. Mutant mouse models of depression: candidate genes and current mouse lines.
     Neurosci Biobehav Rev, 29(4): 805-28. [Abstract] [Full-text]
133. Stress models of depression: forming genetically vulnerable strains.
     Neurosci Biobehav Rev, 29(4): 799-804. [Abstract] [Full-text]
134. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression.
     Neurosci Biobehav Rev, 29(4): 739-59. [Abstract] [Full-text]
135. Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research.
     Neurosci Biobehav Rev, 29(4): 649-74. [Abstract] [Full-text]
136. The olfactory bulbectomised rat as a model of depression.
     Neurosci Biobehav Rev, 29(4): 627-47. [Abstract] [Full-text]
137. Stress, depression, and anhedonia: caveats concerning animal models.
     Neurosci Biobehav Rev, 29(4): 525-46. [Abstract] [Full-text]
138. Animal models of depression: navigating through the clinical fog.
     Neurosci Biobehav Rev, 29(4): 503-13. [Abstract] [Full-text]
139. Evolved mechanisms in adolescent anxiety and depression symptoms: the role of the attachment and social rank systems.
     J Adolesc, 28(3): 325-41. [Abstract] [Full-text]
140. Depression in pregnant women seeking smoking cessation treatment.
     Addict Behav, 30(6): 1195-208. [Abstract] [Full-text]
141. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism.
     Addict Behav, 30(6): 1144-53. [Abstract] [Full-text]
142. Analysis of factors affecting pain in intravenous catheter placement: a survey of 925 patients.
     Int J Clin Pract, 59(6): 675-9. [Abstract] [Full-text]
143. The lived experience of postpartum depression in a psychiatric population.
     Perspect Psychiatr Care, 41(2): 52-61. [Abstract] [Full-text]
144. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.
     Neurosci Biobehav Rev, 29(4): 547-69. [Abstract] [Full-text]
145. Psychostimulant withdrawal as an inducing condition in animal models of depression.
     Neurosci Biobehav Rev, 29(4): 675-706. [Abstract] [Full-text]
146. What should animal models of depression model?
     Neurosci Biobehav Rev, 29(4): 515-23. [Abstract] [Full-text]
147. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.
     Neurosci Biobehav Rev, 29(4): 571-625. [Abstract] [Full-text]
148. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.
     Neurosci Biobehav Rev, 29(4): 771-83. [Abstract] [Full-text]
149. Cytokines as mediators of depression: what can we learn from animal studies?
     Neurosci Biobehav Rev, 29(4): 891-909. [Abstract] [Full-text]
150. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.
     Neurosci Biobehav Rev, 29(4): 761-70. [Abstract] [Full-text]
151. Novelty reward as a measure of anhedonia.
     Neurosci Biobehav Rev, 29(4): 707-14. [Abstract] [Full-text]
152. Dominant-submissive behavior as models of mania and depression.
     Neurosci Biobehav Rev, 29(4): 715-37. [Abstract] [Full-text]

© 2004-2008 Depression Research Today. All Rights Reserved.